Epigral Limited has informed the Exchange about Conference Call on Monday, 27th July, 2026 to discuss Q1 FY27 Results

22.07.2026 National Stock Exchange of India Limited BSE Limited “Exchange Plaza”, Floor- 25, P J Tower, Bandra-Kurla Complex, Dalal Street, Bandra (East) Mumbai 400 051 Mumbai 400 001 SCRIP CODE: EPIGRAL SCRIP CODE: 543332 Dear Sir/s, Sub: Conference Call on Monday, 27th July, 2026 to discuss Q1 FY27 Results With reference to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral Limited (“the Company”) hereby inform that the Conference Call to discuss Q1 FY27 Results is organized on Monday, 27th July, 2026 at 5.00 P.M. (IST) as per details attached. We request you to take note of the above and place it for information of members. Thanking you, Yours faithfully, For Epigral Limited Gaurang Trivedi Company Secretary & Compliance Officer M. No. A22307 EMKAY GLOBAL FINANCIAL SERVICES LTD is pleased to invite you for a conference call to discuss 1QFY27 results with Maulik Patel – Chairman and Managing Director Kaushal Soparkar – Executive Director Rakesh Agrawal – Chief Financial Officer Milind Kotecha – Investor Relations and Strategy Epigral Limited On Monday, July 27, 2026, at 5:00 PM (IST) Pre-register to avoid wait time and Express Join with DiamondPass Dial-in Numbers Universal Access: +91 22 6280 1325/ +91 22 7115 8226 International Toll Free: Argentina: 0080014243444 / Australia: 0080014243444 / Belgium: 0080014243444 / Canada: 01180014243444 / China: 4008428405 / France: 0800914745 / Germany: 0080014243444 / Hong Kong: 800964448 / Italy: 0080014243444 / Japan: 00531161110 / Netherlands: 08000229808 / Poland: 008001124248 / Singapore: 8001012045 / South Korea: 00180014243444 / Sweden: 0080014243444 / Thailand: 00180014243444 / UK: 08081011573 / USA: 18667462133 For further information, please contact: Sabri Hazarika sabri.hazarika@emkayglobal.com Tel: +91 22 6612 1282